Tag

EBR: UCB

UCB wins FDA approval for ZILBRYSQ autoinjector ahead of 2027 launch
Adrian Kessler · Oct 17, 2026
Stoke Therapeutics details Dravet cognition analysis after FDA meeting
Adrian Kessler · Oct 5, 2026